Syneos Health, Inc.
SYNHDelisted Sep 28, 2023- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001610950
Syneos Health, Inc. was delisted on Sep 28, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.32B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.
Superinvestors holding SYNH, Q2 2023
2 superinvestors report holding Syneos Health, Inc. on Form 13F, worth $139.9M in total. Weight is Syneos Health, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Elliott Investment ManagementPaul Singer | 1.7% | 3,299,476 | $139.0M | New |
| Southeastern Asset Management (Longleaf)Mason Hawkins | <0.1% | 19,655 | $828.3K | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SYNH each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
2 superinvestors holding at quarter end
Q1 2023
1 superinvestor holding at quarter end
- Added
- Southeastern Asset Management (Longleaf) (+86.3%)
Q3 2022
1 superinvestor holding at quarter end
- Sold out
- Maverick Capital
Q2 2022
2 superinvestors holding at quarter end
- Added
- Maverick Capital (+100.4%)
Q1 2022
2 superinvestors holding at quarter end
- New
- Southeastern Asset Management (Longleaf)
- Added
- Maverick Capital (+350.6%)
Q4 2021
1 superinvestor holding at quarter end